Human respiratory syncytial virus and other viral infections in infants receiving palivizumab

BACKGROUND: Palivizumab is a humanized monoclonal antibody that prevents severe human respiratory syncytial virus (HRSV) infections. OBJECTIVES: We determined the etiology of respiratory viral infections in palivizumab recipients, and monitored the clinical outcome and HRSV genotype in HRSV-infected...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Clin Virol
Prif Awduron: Boivin, Guy, Caouette, Georges, Frenette, Line, Carbonneau, Julie, Ouakki, Manale, De Serres, Gaston
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier B.V. 2008
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7172843/
https://ncbi.nlm.nih.gov/pubmed/18164233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2007.11.012
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg